Czech Republic - Hospital Average Length of Stay for Carcinoma in Situ
Since 2014, Czech Republic Hospital Average Length of Stay for Carcinoma in Situ was down by 2.8% year on year. In 2019, the country was number 11 comparing other countries in Hospital Average Length of Stay for Carcinoma in Situ with 3.9 Days. South Korea lead the ranking with 7.5 Days in 2019, a decrease of 2.6% versus 2018. Slovakia, Latvia and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +10.6% per year, while New Zealand recorded the worst performance at -8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 3.90 |
| 2018 | 4.20 |
| 2017 | 3.80 |
| 2016 | 4.10 |
| 2015 | 4.10 |
Download all data from 2000 to 2019
How does Czech Republic rank in Hospital Average Length of Stay for Carcinoma in Situ?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
7.50 | 2019 | -2.6 % | +0.8 % | View data | |
| 2 |
#2
Slovakia
|
5.40 | 2019 | +0.0 % | +0.4 % | View data | |
| 10 |
#10
Spain
|
4.00 | 2019 | +0.0 % | -1.9 % | View data | |
| 11 |
#11
Czech Republic
|
3.90 | 2019 | -7.1 % | -2.8 % | View data | |
| 11 |
#11
Hungary
|
3.90 | 2019 | +0.0 % | -2.4 % | View data | |